This pronounced effect could be due to the more distinctive ability of RAD11 to alleviate the augmented accumulation of MPO, as well as MDA- and 4-HNE-protein adducts in the liver, caused by CDAHFD-induced MASH. This evidence concerns the gene MPO and metabolic dysfunction-associated steatohepatitis.